Clinical Trial Update: Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial of human insulin inhalation powder in patients with Type 1 diabetes has completed, sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Human insulin inhalation powder (insulin inhalation powder)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED